References
- Autar, D. K., Egwu, K., and Nguyen, D. (2011). Numerical Methods with Applications, Textbooks Collection: University of South Florida.
- Belongia, E. A., Irving, S. A., Shui, I. M., Kulldorff, M., Lewis, E., Yin, R., Lieu, T. A., Weintraub, E., Yih, W. K., Li, R., Baggs, J., and the Vaccine Safety Datalink Investigation Group (2010). Real-time Surveillance to Assess Risk of Intussusception and Other Adverse Events after Pentavalent, bovine-derived Rotavirus Vaccine, Pediatric Infectious Disease Journal 29: 1–5.
- Davis, R. L. (2013). Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink’s Rapid Cycle Analysis Capabilities, Pharmaceutics 5: 168–178.
- Jennison, C. and Turnbull, B. W. (2000). Group Sequential Methods with Applications to Clinical Trials, London: CRC.
- Klein, N. P., Fireman, B., Yih, W. K., Lewis, E., Kulldorff, M., Ray, P., Baxter, R., Hambidge, S., Nordin, J., Naleway, A., Belongia, E. A., Lieu, T., Baggs, J., Weintraub, E., and the Vaccine Safety Datalink (2010). Measles-Mumps-Rubella-Varicella Combination Vaccine and Risk of Febrile Seizures, Pediatrics 126: e1–e8.
- Kulldorff, M., Davis, R. L., Kolczak, M., Lewis, E., Lieu, T., and Platt, R. (2011). A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance, Sequential Analysis 30: 58–78.
- Kulldorff, M. and Silva, I. R. (2017). Continuous Post-Market Sequential Safety Surveillance with Minimum Events to Signal, Revstat Statistical Journal 15: 373–394.
- Leite, A., Andrews, N. J., and Thomas, S. L. (2016). Near Real-time Vaccine Safety Surveillance Using Electronic Health Records a Systematic Review of the Application of Statistical Methods, Pharmacoepidemiology and Drug Safety 25: 225–237.
- Li, L., and Kulldorff, M. (2009). A Conditional Maximized Sequential Probability Ratio Test for Pharmacovigilance, Statistics in Medicine 29: 284–295.
- Li, R., Stewart, B., Weintraub, E., and McNeil, M. M. (2014). Continuous Sequential Boundaries for Vaccine Safety Surveillance, Statistics in Medicine 33(19): 3387–3397.
- Nelson, J., Cook, A., Yu, O., Dominguez, C., Zhao, S., Greene, S., Fireman, B., Jacobsen, S., Weintraub, E., and Jackson, L. (2012). Challenges in the Design and Analysis of Sequentially Monitored Postmarket Safety Surveillance Evaluations Using Eletronic Observational Health Care Data, Pharmacoepidemiology and Drug Safety 21: 62–71.
- Silva, I. R. (2018). Type I Error Probability Spending for Post-market Drug and Vaccine Safety Surveillance with Binomial Data, Statistics in Medicine 37: 107–118.
- Silva, I. R. and Kulldorff, M. (2013). Sequential-package, Vienna: R Foundation for Statistical Computing, http://www.R-project.org.
- Silva, I. R. and Kulldorff, M. (2015). Continuous Versus Group Sequential Analysis for Post-Market Drug and Vaccine Safety Surveillance, Biometrics 71: 851–858.
- Team, R. C. (2014). (2015). A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna: http://www.R-project.org.
- Yih, W. K., Kulldorff, M., Fireman, B. H., Shui, I. M., Lewis, E. M., Klein, N. P., Baggs, J., Weintraub, E. S., Belongia, E. A., Naleway, A., Gee, J., Platt, R., and Lieu, T. A. (2011). Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project, Pediatrics 127: 54–64.
- Yih, W. K., Nordin, J. D., Kulldorff, M., Lewis, E., Lieu, T. A., Shi, P., and Weintraub, E. S. (2009). An Assessment of the Aafety Datalink of Adolescent and Adult Tetanus-diphteria-acellular Pertussis (Tdap) Vaccine, Using Active Surveillance for Adverse Events in the Vaccine Safety Datalink, Vaccine 27: 4257–4262.
- Zhao, S., Cook, A., Jackson, L., and Nelson, J. (2012). Statistical Performance of Group Sequential Methods for Observational Post-Licensure Medical Product Safety Surveillance: A Simulation Study, Statistics and Its Interface 5: 381–390.